- Joined
- Jul 13, 2012
- Messages
- 47,695
- Reaction score
- 10,467
- Gender
- Male
- Political Leaning
- Other
The statewide premium increase is directly correlated to how many people in that state receive the federal CSR subsidy.
Patients who receive a subsidy will still receive healthcare, but the cost will now be borne by the non-subsidized in that state due to Trump ending federal CSR subsidy payments.
Let's take Louisiana as an example. ~64.3% required the Cost Sharing Reduction federal subsidy. But Trump ended the CSR federal subsidy payments.
What happens then is that the entire Louisiana subsidy cost is borne by the ~35.7% of people in Louisiana that do not receive the CSR federal subsidy.
Their premiums increase by 45% to cover the subsidy shortfall in Louisiana that Trump created by withholding federal payments.
It works this way in every state, but every state has a different % of CSR subsidized so the numbers change per state.
Trumps CSR action hurts Mississippi (77.6%) the most and Minnesota (16.4%) the least. Capiche?
So, what you wrote reads like, the actual cost is not affected.
The impact is that the costs will be re-distributed.
Is that correct?